Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias
- PMID: 16276004
- PMCID: PMC3851114
- DOI: 10.1155/2005/218759
Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias
Abstract
It is now widely accepted that there is a need for the development of molecular markers of cancer that can be used for clinical prognostication and monitoring. Approximately a decade ago tumor-derived circulating nucleic acids in the plasma or serum (CNAPS) of cancer patients were introduced as a noninvasive tool for cancer detection. This review focuses on the various types of CNAPS of patients with solid neoplasias (genetic alterations in circulating DNA, microsatellites, methylated DNA, viral DNA, nucleosomes, mitochondrial DNA and cell-free mRNA) and their putative potential as prognostic or predictive parameter or even as a tool for therapy monitoring during follow-up. Additionally, this review aims to point out the difference between a prognostic and a predictive factor in patient bloodstream. However, with rapid technical improvement and well-designed studies we conclude that the next years will see CNAPS analysis integrated in the prognostication and monitoring of cancer patients, thus producing more specific treatment regimens for patients with various stages of neoplastic disease and ultimately longer survival and better quality of life.
Similar articles
-
Circulating nucleic acids as a potential source for cancer biomarkers.Curr Mol Med. 2010 Mar;10(2):142-65. doi: 10.2174/156652410790963295. Curr Mol Med. 2010. PMID: 20196731 Review.
-
Diagnostic potential of circulating nucleic acids for oncology.Expert Rev Mol Diagn. 2003 Jul;3(4):431-42. doi: 10.1586/14737159.3.4.431. Expert Rev Mol Diagn. 2003. PMID: 12877383 Review.
-
Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue.Histol Histopathol. 2004 Apr;19(2):575-83. doi: 10.14670/HH-19.575. Histol Histopathol. 2004. PMID: 15024717 Review.
-
Circulating nucleic acids as a tumor marker.Histol Histopathol. 2002;17(3):937-43. doi: 10.14670/HH-17.937. Histol Histopathol. 2002. PMID: 12168805 Review.
-
Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?Cancer Biomark. 2010;6(3-4):211-9. doi: 10.3233/CBM-2009-0131. Cancer Biomark. 2010. PMID: 20660966 Review.
Cited by
-
PTSD and DNA Methylation in Select Immune Function Gene Promoter Regions: A Repeated Measures Case-Control Study of U.S. Military Service Members.Front Psychiatry. 2013 Jun 24;4:56. doi: 10.3389/fpsyt.2013.00056. eCollection 2013. Front Psychiatry. 2013. PMID: 23805108 Free PMC article.
-
DNA methylation as clinically useful biomarkers-light at the end of the tunnel.Pharmaceuticals (Basel). 2012 Jan 18;5(1):94-113. doi: 10.3390/ph5010094. Pharmaceuticals (Basel). 2012. PMID: 24288045 Free PMC article.
-
Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection.J Cancer. 2013;4(3):210-6. doi: 10.7150/jca.5839. Epub 2013 Mar 1. J Cancer. 2013. PMID: 23459561 Free PMC article.
-
Circulating mutant DNA to assess tumor dynamics.Nat Med. 2008 Sep;14(9):985-90. doi: 10.1038/nm.1789. Epub 2007 Jul 31. Nat Med. 2008. PMID: 18670422 Free PMC article.
-
Defining the blueprint of the cancer genome.Carcinogenesis. 2008 Jun;29(6):1087-91. doi: 10.1093/carcin/bgn096. Epub 2008 May 20. Carcinogenesis. 2008. PMID: 18495658 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources